Institute of Cell Biology and Neurobiology, National Research Council, Fondazione Santa Lucia, 00143 Rome, Italy.
J Neurosci. 2012 Oct 31;32(44):15547-64. doi: 10.1523/JNEUROSCI.0412-12.2012.
A failure in the control of proliferation of cerebellar granule neuron precursor cells (GCPs), located in the external granular layer (EGL) of the cerebellum, gives rise to medulloblastoma. To investigate the process of neoplastic transformation of GCPs, we generated a new medulloblastoma model by crossing Patched1 heterozygous mice, which develop medulloblastomas with low frequency, with mice lacking the Tis21 gene. Overexpression of Tis21 is known to inhibit proliferation and trigger differentiation of GCPs; its expression decreases in human medulloblastomas. Double-knock-out mice show a striking increase in the frequency of medulloblastomas and hyperplastic EGL lesions, formed by preneoplastic GCPs. Tis21 deletion does not affect the proliferation of GCPs but inhibits their differentiation and, chiefly, their intrinsic ability to migrate outside the EGL. This defect of migration may represent an important step in medulloblastoma formation, as GCPs, remaining longer in the EGL proliferative niche, may become more prone to transformation. By genome-wide analysis, we identified the chemokine Cxcl3 as a target of Tis21. Cxcl3 is downregulated in Tis21-null GCPs of EGL and lesions; addition of Cxcl3 to cerebellar slices rescues the defective migration of Tis21-null GCPs and, remarkably, reduces the area of hyperplastic lesions. As Tis21 activates Cxcl3 transcription, our results suggest that Tis21 induces migration of GCPs through Cxcl3, which may represent a novel target for medulloblastoma therapy.
小脑颗粒神经元前体细胞(GCP)在小脑的外颗粒层(EGL)中增殖失控,导致成神经管细胞瘤。为了研究 GCP 肿瘤转化的过程,我们通过杂交 Patched1 杂合子小鼠(其成神经管细胞瘤的发病率较低)和缺乏 Tis21 基因的小鼠,生成了一种新的成神经管细胞瘤模型。Tis21 的过度表达已知会抑制 GCP 的增殖并触发其分化;其在人类成神经管细胞瘤中的表达降低。双敲除小鼠成神经管细胞瘤和由前神经瘤 GCP 形成的 EGL 增生病变的发生率显著增加。Tis21 缺失不影响 GCP 的增殖,但会抑制其分化,主要是抑制其内在的向 EGL 外迁移的能力。这种迁移缺陷可能是成神经管细胞瘤形成的一个重要步骤,因为 GCP 在 EGL 增殖龛中停留的时间更长,可能更容易发生转化。通过全基因组分析,我们鉴定了趋化因子 Cxcl3 是 Tis21 的靶标。Cxcl3 在 EGL 和病变中 Tis21 缺失的 GCP 中下调;向小脑切片中添加 Cxcl3 可挽救 Tis21 缺失的 GCP 的迁移缺陷,并显著减少增生病变的面积。由于 Tis21 激活 Cxcl3 的转录,我们的结果表明 Tis21 通过 Cxcl3 诱导 GCP 的迁移,这可能是成神经管细胞瘤治疗的一个新靶点。